Polonium subjects were chosen because experimenters wanted persons who had not been exposed to polonium either through work or accident. All subjects had incurable diseases. Excretion of polonium was followed, and an autopsy was conducted at that time on the deceased patient to determine which organs absorbed the polonium. Patients' ages ranged from 'early thirties' to 'early forties'. The experiments were described in Chapter 3 of Biological Studies with Polonium, Radium, and Plutonium, National Nuclear Energy Series, Volume VI-3, McGraw-Hill, New York, 1950. Not specified is the isotope under study, but at the time polonium-210 was the most readily available polonium
Polonium in biological specimens by alpha particle spectrometry to confirm a diagnosis of poisoning in hospitalized patients or to provide evidence in a medicolegal death investigation. The baseline urinary excretion of polonium-210 in healthy persons due to routine exposure to environmental sources is normally in a range of 5–15 mBq/day. Levels in excess of 30 mBq/day are suggestive of excessive exposure to the radionuclide. Polonium-210 is widespread in the biosphere, including in human tissues, because of its position in the uranium-238 decay chain. Natural uranium-238 in the Earth's crust decays through a series of solid radioactive intermediates including radium-226 to the